Treatment workload by stage and subtype in patients with breast cancer: A SEER-Medicare analysis.

被引：0
|
作者：
Cheng, Alex
Warner, Jeremy Lyle
Levy, Mia Alyce
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[2] Rush Univ, Med Ctr, Div Hematol Oncol & Cell Therapy, Chicago, IL 60612 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19328
引用
收藏
页数：2
相关论文
共 50 条
  • [41] TIMING OF PHYSICIAN VISITS AND THE IMPACT ON SURVIVAL AMONG SEER-MEDICARE PATIENTS WITH STAGE IV PROSTATE CANCER
    Onukwugha, E. E.
    Mullins, C. D.
    Seal, B.
    Hussain, A.
    VALUE IN HEALTH, 2009, 12 (03) : A38 - A38
  • [42] Racial Disparities in Breast Cancer Treatments and Adverse Events in the SEER-Medicare Data
    Wieder, Robert
    Adam, Nabil
    CANCERS, 2023, 15 (17)
  • [43] PATTERNS OF CARE AND LOCOREGIONAL TREATMENT OUTCOMES IN OLDER ESOPHAGEAL CANCER PATIENTS: THE SEER-MEDICARE COHORT
    Smith, Grace L.
    Smith, Benjamin D.
    Buchholz, Thomas A.
    Liao, Zhongxing
    Jeter, Melenda
    Swisher, Stephen G.
    Hofstetter, Wayne L.
    Ajani, Jaffer A.
    McAleer, Mary F.
    Komaki, Ritsuko
    Cox, James D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 74 (02): : 482 - 489
  • [44] Outcomes and Utilization of Adjuvant Chemotherapy for Stage II Colon Cancer in the Oxaliplatin Period A SEER-Medicare Analysis
    Jiao, Xiayu
    Hay, Joel W.
    Sadeghi, Sarmad
    Barzi, Afsaneh
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (06): : 428 - 434
  • [45] Opioids and Sleep Medication Use After Surgery for Early Stage Lung Cancer: A SEER-Medicare Analysis
    Tuminello, S.
    Wisnivesky, J.
    Schwartz, R.
    Liu, B.
    Mhango, G.
    Flores, R. R.
    Taioli, E.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S355 - S355
  • [46] Opportunities for personalizing colorectal cancer care: an analysis of SEER-medicare data
    Zachary T. Rivers
    Helen M. Parsons
    Pamala A. Jacobson
    Karen M. Kuntz
    Joel F. Farley
    David J. Stenehjem
    The Pharmacogenomics Journal, 2022, 22 : 198 - 209
  • [47] Incidence and time course of surgical complications by cancer stage and site among Medicare patients undergoing elective colorectal resection for cancer: An analysis of the SEER-Medicare database
    Johnston, Stephen
    Ammann, Eric
    Nayak, Akhil
    Nagle, Deborah
    Patkar, Anuprita
    Charlton, Mary
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 94 - 95
  • [48] Treatment patterns and burden of myelosuppression for patients with small cell lung cancer: A SEER-medicare study
    Epstein, Robert S.
    Nelms, Jerrod
    Moran, Donald
    Girman, Cynthia
    Huang, Huan
    Chioda, Marc
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2022, 31
  • [49] A SEER-Medicare analysis of the impact of metformin on overall survival in ovarian cancer
    Garcia, Christine
    Yao, Aaron
    Camacho, Fabian
    Balkrishnan, Rajesh
    Cantrell, Leigh A.
    GYNECOLOGIC ONCOLOGY, 2017, 146 (02) : 346 - 350
  • [50] Opportunities for personalizing colorectal cancer care: an analysis of SEER-medicare data
    Rivers, Zachary T.
    Parsons, Helen M.
    Jacobson, Pamala A.
    Kuntz, Karen M.
    Farley, Joel F.
    Stenehjem, David J.
    PHARMACOGENOMICS JOURNAL, 2022, 22 (03): : 198 - 209
12345